|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities | ||||||||||||||||||||
| Available for sale, at fair value (amortized cost $159,483 and $163,376, respectively) | ||||||||||||||||||||
| Held to maturity, at amortized cost (fair value $777,383 and $805,428, respectively) | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Loans held for sale, at lower of cost or fair value | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Residential Mortgage | ||||||||||||||||||||
| Commercial Mortgage | ||||||||||||||||||||
| Home Equity | ||||||||||||||||||||
| Commercial & Industrial | ||||||||||||||||||||
| Consumer | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less: allowance for credit losses on loans | ||||||||||||||||||||
| Total less: allowance for credit losses on loans | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Federal Home Loan Bank of Boston Stock, at cost | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Banking premises and equipment, net | ||||||||||||||||||||
| Right-of-use asset operating leases | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Merger-related intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Demand | ||||||||||||||||||||
| Demand- Non Interest bearing | ||||||||||||||||||||
| Interest-bearing checking | ||||||||||||||||||||
| Money market | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Certificates of deposit | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common stock, par value $1.00; Authorized: 10,000,000 shares; Outstanding: 7,845,598 shares and 7,845,452 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
